For: | Catena C, Colussi G, Nait F, Pezzutto F, Martinis F, Sechi LA. Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state. World J Nephrol 2015; 4(3): 374-378 [PMID: 26167461 DOI: 10.5527/wjn.v4.i3.374] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v4/i3/374.htm |
Number | Citing Articles |
1 |
Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, Alessandro Picci, Filippo Capilupi, Patrizio Capilupi, Luca Bulfone, Antonio Vacca, Nicole Bertin, Cinzia Vivarelli, Jacopo Comand, Cristiana Catena, Leonardo A. Sechi. Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?. International Journal of Molecular Sciences 2023; 24(17): 13363 doi: 10.3390/ijms241713363
|
2 |
Hans Dieplinger. Lipoprotein(a). Contemporary Cardiology 2023; : 207 doi: 10.1007/978-3-031-24575-6_12
|
3 |
Jing Yao, Lijuan Jiang, Dong Xue, Yanbei Sun. Predictive value of procalcitonin in chronic allograft dysfunction in kidney transplant recipients. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8113
|
4 |
Zhidong Huang, Yanfang Yang, Jin Lu, Jingjing Liang, Yibo He, Yaren Yu, Haozhang Huang, Qiang Li, Bo Wang, Shanggang Li, Zelin Yan, Danyuan Xu, Yong Liu, Kaihong Chen, Zhigang Huang, Jindong Ni, Jin Liu, Liling Chen, Shiqun Chen. Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.747120
|
5 |
Dan Su, Jian Luo, Junqi Ge, Yali Liu, Chen Jin, Pengfei Xu, Ruowen Zhang, Genhua Zhu, Ming Yang, Zhifu Ai, Yonggui Song. Raw and Wine Processed Schisandra chinensis Regulate
NREM-Sleep and Alleviate Cardiovascular Dysfunction Associated with Insomnia by
Modulating HPA Axis. Planta Medica 2022; 88(14): 1311 doi: 10.1055/a-1721-4971
|
6 |
Yunhui Zhu, Songzan Chen, Zhebin Chen, Yao Wang, Guosheng Fu, Wenbin Zhang. Causal effect of lipoprotein(a) level on chronic kidney disease of European ancestry: a two-sample Mendelian randomization study. Renal Failure 2024; 46(2) doi: 10.1080/0886022X.2024.2383727
|
7 |
Jemma C. Hopewell, Richard Haynes, Colin Baigent. The role of lipoprotein (a) in chronic kidney disease. Journal of Lipid Research 2018; 59(4): 577 doi: 10.1194/jlr.R083626
|
8 |
Na Xu, Xiao-fang Tang, Yi Yao, Xue-yan Zhao, Jue Chen, Zhan Gao, Shu-bin Qiao, Yue-jin Yang, Run-Lin Gao, Bo Xu, Jin-Qing Yuan. Association of Plasma Lipoprotein(a) With Long-Term Adverse Events in Patients With Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention. The American Journal of Cardiology 2018; 122(12): 2043 doi: 10.1016/j.amjcard.2018.04.058
|
9 |
Na Xu, Lin Jiang, Lianjun Xu, Jian Tian, Ce Zhang, Xueyan Zhao, Xinxing Feng, Dong Wang, Yin Zhang, Kai Sun, Jingjing Xu, Ru Liu, Bo Xu, Wei Zhao, Rutai Hui, Runlin Gao, Zhan Gao, Lei Song, Jinqing Yuan. Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease. The American Journal of Cardiology 2020; 125(4): 528 doi: 10.1016/j.amjcard.2019.10.037
|